Top

Published in:

01-02-2015 | Original Article

Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994–2011

Authors: Dita Maixnerova, Eva Jancova, Jelena Skibova, Romana Rysava, Ivan Rychlik, Ondrej Viklicky, Miroslav Merta, Alexander Kolsky, Jana Reiterova, Michaela Neprasova, Jana Kidorova, Eva Honsova, Vladimir Tesar

Published in: Journal of Nephrology | Issue 1/2015

Abstract

Background

We describe data on 10,472 renal biopsies gathered by the Czech Registry of Renal Biopsies over a period of 18 years.

Methods

We assessed the main demographic, clinical and histological data of individuals who underwent renal biopsies of native kidneys in 31 centers in the Czech Republic (population 10.3 million) during the period 1994–2011.

Results

We evaluated 10,472 renal biopsies: males 57.8 %, children (≤15 years) 13.6 %, elderly (>60 years) 19.1 %. The most frequent biopsy-proven diseases were primary (55.7 %) and secondary (29.1 %) glomerulonephritides (GN). Tubulointerstitial nephritis (TIN) was observed in 3.4 % and vascular diseases in 4.1 %. The samples were non-diagnostic in 4.2 %. Among primary GN the most frequent diagnoses were IgA nephropathy (IgAN) (37.4 %), membranous GN (MGN) (13 %) and focal segmental glomerulosclerosis (FSGS) (12.6 %). Among secondary GN, systemic lupus erythematosus (SLE) represented 23.2 %, hereditary diseases 19.8 % and necrotizing vasculitis (NV) 19.4 %. Among adults, mild renal insufficiency [serum creatinine (SCr) 111–200 μmol/l] was present in 24.7 %, advanced renal insufficiency (SCr 201–400 μmol/l) in 15.3, and 12.3 % of patients had SCr > 400 μmol/l. The most common diseases in patients with nephrotic proteinuria were minimal change disease (MCD) (39.7 %) among children, IgAN (26.2 %) in adults aged 16–60 years and amyloidosis (42.7 %) among the elderly. The mean annual incidence (per million population) was: primary GN 30.9, secondary GN 18.1, IgAN 11.6, MGN 4.0, SLE 4.0, FSGS 3.9, MCD 3.4, NV 3.2, diabetic nephropathy 2.3, thin basement membrane glomerulopathy 2.0, mesangioproliferative GN 1.9, and TIN 1.9. Ultrasound needle guidance was used in 66.8 %. The frequency of serious complications (symptomatic hematoma, gross hematuria, blood transfusion) was approximately 3.2 %.

Conclusions

This report provides representative population-based data on native biopsy-proven renal diseases in the Czech Republic. Over the 18 years of nationwide biopsy survey, we noted an increase of the mean age of renal biopsy cases, an increasing proportion of elderly, and a cardinal change in biopsy technique towards ultrasonography needle guidance.

Rychlík I, Jančová E, Tesař V et al (2004) The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994–2000. Nephrol Dial Transplant 19:3040–3049CrossRefPubMed

Churg J, Bernstein J, Glassock R (1995) Renal disease: Classification and atlas of glomerular diseases, 2nd edn. IGAKU-SHOIN Medical Publishers, Inc. New York (ISBN: 0-89640-257-6)

Schena P, Gesualdo L (1994) Renal biopsy beyond histology and immunofluorescence. Nephrol Dial Transplant 9:1541–1544PubMed

Heaf J, Lokkegaard H, Larsen S (1999) The epidemiology and prognosis of glomerulonephritis in Denmark 1985–1997. Nephrol Dial Transplant 14:1889–1897CrossRefPubMed

Rivera F, López-Gómez JM, Pérez-García R, Spanish registry of glomerulonephritis (2002) Frequency of renal pathology in Spain 1994–1999. Nephrol Dial Transplant 17(9):1594–1602

Braun N, Schweisfurth A, Lohofener Ch et al (2011) Epidemiology of glomerulonephritis in Northern Germany. Int Urol Nephrol 43:1117–1126CrossRefPubMed

McQuarrie EP, Mackinnon B, Young B et al (2009) Centre variation in incidence, indication and diagnosis of adult native renal biopsy in Scotland. Nephrol Dial Transplant 24:1524–1528CrossRefPubMed

Hanko JB, Mullan RN, O´Rourke DM et al (2009) The changing pattern of adult primary glomerular disease. Nephrol Dial Transplant 24:3050–3054CrossRefPubMed

Naumovic R, Pavlovic S, Stojkovic D et al (2009) Renal biopsy registry from a single centre in Serbia: 20 years of experience. Nephrol Dial Transplant 24:877–885CrossRefPubMed

10.

Covic A, Schiller A, Volovat C et al (2006) Epidemiology of renal disease in Romania: a 10 year review of two regional renal biopsy databases. Nephrol Dial Transplant 21:419–424CrossRefPubMed

11.

Simon P, Ramee MP, Boulahrouz R et al (2004) Epidemiologic data of primary glomerular diseases in western France. Kidney Int 66:905–908CrossRefPubMed

12.

Wirta O, Mustonen J, Helin H et al (2008) Incidence of biopsy-proven glomerulonephritis. Nephrol Dial Transplant 23:193–200CrossRefPubMed

13.

Briganti EM, Dowling J, Finlay M et al (2001) The incidence of biopsy-proven glomerulonephritis in Australia. Nephrol Dial Transplant 16:1364–1367CrossRefPubMed

14.

Okpechi I, Swanepoel Ch, Duffield M et al (2011) Patterns of renal disease in Cape Town South Africa: a 10-year review of a single-centre renal biopsy database. Nephrol Dial Transplant 26:1853–1861CrossRefPubMed

15.

Simon P, Ramée MP, Autuly V et al (1994) Epidemiology of primary glomerular disease in a French region. Variations according to period and age. Kidney Int 46:1192–1198CrossRefPubMed

16.

Coppo R, Gianoglio B, Porcellini MG et al (1998) Frequency of renal diseases and clinical indications for renal biopsy in children (report of the Italian National Registry of Renal Biopsies in Children). Nephrol Dial Transplant 13:293–297CrossRefPubMed

17.

McGrogan A, Franssen CF, de Vries CS (2011) The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant 26:414–430CrossRefPubMed

18.

Schena FP (1997) Survey of the Italian Registry of Renal Biopsies. Frequency of the renal diseases for 7 consecutive years. Nephrol Dial Transplant 12:418–426CrossRefPubMed

19.

El Reshaid W, El Reshaid K, Kapoor MM et al (2003) Glomerulopathy in Kuwait: the spectrum over the past 7 years. Ren Fail 25:619–630CrossRefPubMed

20.

Swaminathan S, Leung N, Lager DJ et al (2006) Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study. Clin J Am Soc Nephrol 1:483–487CrossRefPubMed

21.

Fischer EG, Harris AA, Carmichael B et al (2009) IgA nephropathy in the triethnic population of New Mexico. Clin Nephrol 72:163–169CrossRefPubMed

22.

Al Arrayed A, George SM, Malik AK et al (2004) The spectrum of glomerular diseases in the kingdom of Bahrain: an epidemiological study based on renal biopsy interpretation. Transplant Proc 36:1792–1795CrossRefPubMed

23.

Al Arrayed A, Shariff S, Maamari MMA (2007) Kidney disease in Bahrain: a biopsy-based epidemiological study. Transplant Proc 4:875–878CrossRef

24.

Wyatt RJ, Julian BA, Baehler RW et al (1998) Epidemiology of IgA nephropathy in central and eastern Kentucky for the period 1975 through 1994. Central Kentucky Region of the South-eastern United States IgA Nephropathy DATABANK Project. J Am Soc Nephrol 9:853–858PubMed

25.

Research Group on Progressive Chronic Renal Disease (1999) Nationwide and long-term survey of primary glomerulonephritis in Japan as observed in 1850 biopsied cases. Nephron 82:205–213CrossRef

26.

Vivante A, Afek A, Frenkel-Nir Y et al (2011) Persistent asymptomatic isolated microscopic haematuria in Israeli adolescents and young adults and risk for end-stage renal disease. JAMA 306:729CrossRefPubMed

27.

Sehic AM, Gaber LW, Roy S III et al (1997) Increased recognition of IgA nephropathy in African-American children. Pediatr Nephrol 11:435–437CrossRefPubMed

28.

Kiryluk K, Li Y, Sanna-Cherchi S et al (2012) Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet 8(6):e1002765. doi:10.1371/journal.pgen.1002765

29.

Izzi C, Sanna-Cherchi S, Prati E et al (2006) Familial aggregation of primary glomerulonephritis in an Italian population isolate: Valtrompia study. Kidney Int 69:1033–1040CrossRefPubMed

30.

Kiryluk K, Novak J, Gharavi AG (2013) Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies. Annu Rev Med 64:339–356CrossRefPubMedCentralPubMed

31.

Wyatt RJ, Julian BA (2013) IgA nephropathy. N Engl J Med 368(25):2402–2414CrossRefPubMed

32.

Novak J, Renfrow MB, Gharavi AG, Julian BA (2013) Pathogenesis of immunoglobulin A nephropathy. Curr Opin Nephrol Hypertens 22(3):287–294

33.

Polito MG, deMoura RA, Kirsztajn GM (2010) An overview on frequency of renal biopsy diagnosis in Brazil: clinical and pathological patterns based on 9617 native kidney biopsies. Nephrol Dial Transplant 25:490–496CrossRefPubMed

34.

Li LS, Liu ZH (2004) Epidemiologic data of renal diseases from a single unit in China: analysis based on 13.519 renal biopsies. Kidney Int 66:920–923CrossRefPubMed

35.

Chang JH, Kim DK, Kim HW et al (2009) Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience. Nephrol Dial Transplant 24:2406–2410CrossRefPubMed

36.

Huraib S, Khader AA, Shaheen FAM et al (2000) The spectrum of glomerulonephritis in Saudi Arabia: the results of the Saudi Registry. Saudi J Kidney Dis Transplant 11(3):434–441

Title: Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994–2011
Authors: Dita Maixnerova
Eva Jancova
Jelena Skibova
Romana Rysava
Ivan Rychlik
Ondrej Viklicky
Miroslav Merta
Alexander Kolsky
Jana Reiterova
Michaela Neprasova
Jana Kidorova
Eva Honsova
Vladimir Tesar
Publication date: 01-02-2015
Publisher: Springer International Publishing
Published in: Journal of Nephrology / Issue 1/2015
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI: https://doi.org/10.1007/s40620-014-0090-z

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2015

Diuretic response to colloid and crystalloid fluid loading in critically ill patients

Renal function to 5 years after late conversion of kidney transplant patients to everolimus: a randomized trial

Effect of oral ferric citrate on serum phosphorus in hemodialysis patients: multicenter, randomized, double-blind, placebo-controlled study

Erratum to: Lupus nephritis in Egyptian children: a 16-year experience

CKD in disadvantaged populations

Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy?

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials